focus -WSS

focus

author：fashion 2025-08-17 00:04:04 - browse：865

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Prior authorization reform is both possible and imperative

explore

WSS

How generative AI is inspiring dreams of a health data revolution

A pediatrician calls for Congress to pass the child tax credit deal

What drug price negotiations mean for Medicare Part D

'Make People Better': The CRISPR babies story you probably don't know

Amazon on where the company's health care bets are headed next

Medicare bonuses could stop drug shortages under Senate plan

focus

focus

Wikipedia

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medicaid rebukes states for mistakenly disenrolling children

Drug repurposing or repositioning? The language matters

Printout prescription drug information shouldn’t go digital

After affirmative action ruling, medical educators look to 'holistic review'

Humana sues Biden admin over Medicare Advantage audit rule

In Memoriam: Notable people who died in 2023

Listen: Biogen's potential pivot, & Illumina's next chapter

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Covid hospitalizations on the rise, Humana says

focus

The (many) problems with a new study criticizing cancer screening

Flu vaccine reformulation won't be easy, manufacturers warn

'Make People Better': The CRISPR babies story you probably don't know

A new House health package & hospitals’ new site

House transparency, PBM reform bill gains bipartisan support

Cardiologists urge adding sexual orientation, gender identity to health records

hotspot

explore

Wikipedia

explore